Use of FDG PET/CT in Patients with Pancoast Tumors: Does It Add Any Contribution to Patient Management?-Reference-Cited by-同舟云学术

Use of FDG PET/CT in Patients with Pancoast Tumors: Does It Add Any Contribution to Patient Management?

Published:2015-10 Issue:8 Volume:30 Page:359-367
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Ozmen Ozlem¹,Yilmaz Ulku²,Dadali Yeliz³,Tatci Ebru¹,Gokcek Atila³,Aydin Ertan⁴,Okuyucu Kursat⁵,Arslan Nuri⁵

Affiliation:

1. Department of Nuclear Medicine, Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey.

2. Department of Chest Diseases, Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey.

3. Department of Radiology, Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey.

4. Department of Chest Surgery, Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey.

5. Department of Nuclear Medicine, Gulhane Military Medical Academy and Medical Faculty, Ankara, Turkey.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2014.1809

Reference32 articles.

1. Superior Pulmonary Sulcus Tumors and Pancoast's Syndrome

2. Management of Pancoast tumours

3. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ipsilateral Hyperhidrosis: Atypical Symptom of Small Lung Adenocarcinoma Evaluated by 18F-FDG PET-CT;Nuclear Medicine and Molecular Imaging;2019-03-26

2. ¿Pueden contribuir los parámetros tumorales metabólicos, establecidos mediante 18 F-FDG PET/TC para estadificación primaria, a la estratificación del riesgo de los linfomas del sistema nervioso central, para el tratamiento del paciente como modelo pronóstico?;Revista Española de Medicina Nuclear e Imagen Molecular;2018-01

3. Can metabolic tumour parameters on primary staging 18 F-FDG-PET/CT contribute to risk stratification of primary central nervous system lymphomas for patient management as a prognostic model?;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2018-01